These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 314343)

  • 1. Immunologic significance of nonspecific suppressor cells in spleens of tumor-bearing mice.
    Hanna N; Kripke ML
    Cell Immunol; 1979 Mar; 43(2):293-303. PubMed ID: 314343
    [No Abstract]   [Full Text] [Related]  

  • 2. Soluble suppressor factor from the spleens of tumor-bearing mice.
    Subramanian C; Yu S; McKhann CF
    Cancer Res; 1978 Jul; 38(7):1996-2002. PubMed ID: 657137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence of suppressor cell activity in spleens of mice bearing primary tumors induced by Moloney sarcoma virus.
    Kirchner H; Chused TM; Herberman RB; Holden HT; Lavrin DH
    J Exp Med; 1974 Jun; 139(6):1473-87. PubMed ID: 4598016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of mitogen and immune blastogenesis by two distinct populations of supressor cells present in the spleens of fibrosarcoma-bearing mice: adoptive transfer of suppression.
    Farrar WL; Elgert KD
    Int J Cancer; 1978 Aug; 22(2):142-51. PubMed ID: 308934
    [No Abstract]   [Full Text] [Related]  

  • 5. Release of soluble "blocking" and "suppressor" factors from normal lymphocytes treated with RNA from spleens of tumour-bearing mice.
    Pennline KJ; Evans SB; Nawrocki JF; Rees JC; Johnson CS; Vallera DA; Dodd MC
    Br J Cancer; 1979 Mar; 39(3):247-58. PubMed ID: 313804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for splenic suppressor cells in C3H/He, T-cell-deprived C3H/He, and nude mice bearing a 3-methylcholanthrene-induced fibrosarcoma.
    Poupon MF; Kolb JP; Lespinats G
    J Natl Cancer Inst; 1976 Dec; 57(6):1241-7. PubMed ID: 1087353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immune response to a chemically induced fibrosarcoma: a comparison of cytolytic T lymphocyte stimulation by transformed and non-transformed fibroblasts.
    Bowlin TL; Proffitt MR
    Cancer Immunol Immunother; 1982; 13(1):30-7. PubMed ID: 6984353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of tumor bearing upon changes in cell distribution and membrane antigen characteristics in murine spleen and thymus cell subpopulations.
    Konda S; Smith RT
    Cancer Res; 1973 Aug; 33(8):1878-84. PubMed ID: 4541721
    [No Abstract]   [Full Text] [Related]  

  • 9. Presence of suppressor cells in spleens of mice bearing a weakly immunogenic syngeneic tumor.
    Gautam SC; Deodhar SD
    Cancer Res; 1979 Aug; 39(8):2945-51. PubMed ID: 313243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of thymus- and bone marrow-derived lymphocytes by tumor cells in culture.
    Burk MW; Yu S; Burk KR; McKhann CF
    Cancer Res; 1977 Feb; 37(2):603-9. PubMed ID: 318923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The stimulatory effects of bearing primary methylcholanthrene-induced tumors upon the murine lymphoreticular system.
    Smith RT; Konda S
    Int J Cancer; 1973 Nov; 12(3):577-88. PubMed ID: 4598649
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of proliferation of lymphoma cells and T lymphocytes by suppressor cells from spleens of tumor-bearing mice.
    Kirchner H; Muchmore AV; Chused TM; Holden HT; Herberman RB
    J Immunol; 1975 Jan; 114(1 Pt 1):206-10. PubMed ID: 122986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discussion paper: in vitro augmentation of tumor immunity in a murine methylcholanthrene sarcoma system.
    Yarlott MA; McKhann CF
    Ann N Y Acad Sci; 1976; 277(00):533-40. PubMed ID: 187102
    [No Abstract]   [Full Text] [Related]  

  • 14. The stimulatory effect of tumor bearing upon the T- and B-cell subpopulations of the mouse spleen.
    Konda S; Nakao Y; Smith RT
    Cancer Res; 1973 Oct; 33(10):2247-56. PubMed ID: 4147496
    [No Abstract]   [Full Text] [Related]  

  • 15. Nonspecific and specific immunosuppression in tumour-bearing mice by soluble immune complexes.
    Gorczynski RM; Kilburn DG; Knight RA; Norbury C; Parker DC; Smith JB
    Nature; 1975 Mar; 254(5496):141-3. PubMed ID: 1078882
    [No Abstract]   [Full Text] [Related]  

  • 16. Lymphocyte mediated cytotoxicity after cryosurgery of a murine sarcoma.
    Bagley DH; Faraci RP; Marrone JC; Beazley RM
    J Surg Res; 1974 Dec; 17(6):404-6. PubMed ID: 4437162
    [No Abstract]   [Full Text] [Related]  

  • 17. Suppressor cells in tumor-bearing mice capable of nonspecific blocking of in vitro immunization against transplant antigens.
    Eggers AE; Wunderlich JR
    J Immunol; 1975 May; 114(5):1554-6. PubMed ID: 123545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adherent cells (macrophages?) in tumor-bearing mice suppress MLC responses.
    Garrigues HJ; Romero P; Hellström I; Hellström KE
    Cell Immunol; 1981 May; 60(1):109-18. PubMed ID: 6453654
    [No Abstract]   [Full Text] [Related]  

  • 19. Enhancement of T cell MLR reactivity by addition of macrophage supernatants from tumor-bearing mice.
    Elgert KD; Connolly KM
    Oncology; 1980; 37(2):101-6. PubMed ID: 6444706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo effects of rabbit anti-mouse brain serum on theta bearing lymphocytes of AKR mice.
    Filppi JA; Rheins MS; Pierre RL
    Immunology; 1975 Apr; 28(4):659-68. PubMed ID: 1097331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.